• Molecular NameBifemelane
  • SynonymNA
  • Weight269.388
  • Drugbank_IDN/A
  • ACS_NO90293-01-9
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)3.72
  • pkaN/A
  • LogD (pH=7, predicted)0.72
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-0.51
  • LogSw (predicted, AB/LogsW2.0)0.03
  • Sw (mg/ml) (predicted, ACD/Labs)0.18
  • No.of HBond Donors1
  • No.of HBond Acceptors2
  • No.of Rotatable Bonds8
  • TPSA21.26
  • StatusN/A
  • AdministrationN/A
  • PharmacologyA drug with neuroprotective, nootropic and antidepressant effects, acting through altered muscarinic acetylcholine function in the brain. It is also useful for the treatment of glaucoma.
  • Absorption_value95.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability13.0
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityLD50=1000 (mice)
  • LD50 (rat)N/A
  • LD50 (mouse)N/A